Mechanisms of Drug Hypersensitivity Reactions
|
|
- Tamsyn Warner
- 6 years ago
- Views:
Transcription
1 18/5/213 Mechanisms of Drug Hypersensitivity Reactions Munir Pirmohamed NHS Chair of Pharmacogenetics Department of Molecular and Clinical Pharmacology Institute of Translational Medicine University of Liverpool Definitions and Manifestations Hypersensitivity an inappropriate immune response leading to an inappropriate immune response leading to tissue damage from an otherwise non toxic agent 1
2 18/5/213 Immune Mediated Adverse Drug Reactions Drug Hypersensitivity Off target toxicity Not predictable from the known pharmacology of a drug Skin is the organ most commonly involved Role of T cells Proliferation of T cells from hypersensitive patients but not non hypersensitive controls Mauri Hellweg et al. J Immunol 155, Prominent cutaneous infiltration of CD4+ and CD8+ T cells Yawalkar et al. Clin Exp Allergy 3, , 2. Drug induced liver injury Stevens Johnson syndrome Toxic epidermal necrolysis Uetrecht & Naisbitt Pharmacol Rev, 65:779 88, 213 Pichler, Naisbitt & Park J Allergy Clin Immunol, 127:74 81, 211 2
3 18/5/213 Genetic Restriction and Drug Hypersensitivity: Discovery of HLA allele associations Discovery of associations between HLA alleles and drug hypersensitivity represents an important advance Screening for HLA alleles during clinical practice effectively prevents reactions Abacavir Carbamazepine Mechanistic studies using samples from volunteers with HLA risk alleles may shed light on the immune pathogenesis Pharmacogenetics and Clinical Syndromes Abacavir HLA B * 571 OR = 132 hypersensitivity Flucloxacillin HLA B * 571 OR = 72 DILI Carbamazepine HLA B * 152 (Chinese) OR = 1 SYS/TEN Carbamazepine HLA A*311 (Japanese) OR = 11 Hypersensitivity Carbamazepine HLA A*311 (Caucasians) OR = 3 Hypersensitivity Lumiracoxib HLA DRB1*151 OR = 7 DILI HLA DQA1*12 Ximelagatran HLA DRB1*71 OR = 4.4 Lapatinib HLA BQA1*21 OR = 9. DILI Mallal, 28; Kindmark et al., 28; Daly et al., 29; Chung et al., 24; McCormack et al., 211; Singer et al., 21; Spraggs et al., 211 Delayed Hypersensitivity Reactions (1) Maculopapular Eruption (MPE) Commonest type of cutaneous eruption Drug withdrawal Symptomatic and supportive treatment 3
4 C es 18/5/213 Delayed Hypersensitivity Reactions (2) Hypersensitivity Syndrome Systemic manifestations estato s Fever, eosinophillia Variable extracutaneous involvement Liver commonest to be affected Anticonvulsant Hypersensitivity Syndrome: Clinical Characteristics Carbamazepine (n=35) Clinical Feature Pneumonitis Aplastic anaemia Thrombocytopenia Lymphadenopathy Liver toxicity Eosinophilia Fever Lamotrigine (n=34) Skin rash N C O NH 2 Carbamazepine C l C l N N % of patients NH 2 N NH 2 Lamotrigine 4
5 18/5/213 Delayed Hypersensitivity Reactions (3) Stevens Johnson Syndrome 1 1% 1% of skin blistered Two mucous membranes involved 1% mortality Delayed Hypersensitivity Reactions (4) Toxic Epidermal Necrolysis >3% of skin blistered Two mucous membranes involved 3% mortality 5
6 18/5/213 Delayed Hypersensitivity Cutaneous Reactions Maculopapular exanthem Hypersensitivity syndrome Stevens Johnson Syndrome Severity Mortality Rarity Toxic Epidermal Necrolysis Phenotypic Heterogeneity Skin Liver Kidney Phenotypic heterogeneity common in drug allergies Same drug can cause different manifestations in different patients Within the same organ, clinical picture can vary Within different patients, a number of organs can be affected Important to have clear phenotypic criteria to allow for phenotype standardisation 6
7 18/5/213 Phenotype is Crucial Clinical Pharmacology and Therapeutics, June 211 Cellular pathophysiology of drug hypersensitivity reactions in skin: characterization of T cell clones Drug T cell CD4+ T cell Revised classification of drug hypersensitivity in skin Proliferation Maculopapular TCR exanthema Bullous Pustular MHC I & II Drug Drug presented antigen on MHC class presenting II cell Drug presented on MHC class I CD4+ > CD8+ CD8+ > CD4+ cytotoxicity (CD4+) cytotoxicity (CD8+) IL 5 > IFN gamma IFN gamma > IL 5 Tissue damage in skin Clonal Drug presented on MHC expansion class II CD4+ and CD8+ cytotoxicity (CD4+ & CD8+) IL 8, IL 5 and IFN gamma CD8+ T cell Anticonvulsant hypersensitivity Drug presented on MHC class I & II CD4+, CD8+ and CD4+CD8+ cytotoxicity (CD8+) IFN gamma, MIP1beta, RANTES CLA, CCR4, CCR8, CCR1 Pichler et al. Am J Clin Dermatol IL 5 3, , IL Pichler Ann Intern Med 139, , 23 Naisbitt et al. Curr Allergy Asthma Rep 3, 22 9, IL 4 IFN γ 23 Naisbitt et al. Expert Opin perforin Drug Saf. 6, 19 24, 27 granzymeb IL 17 MIP 1β TNF alpha granulysin FasL Uetrecht & Naisbitt Pharmacol Rev, 65:779 88, 213 IL 1 IL 22 Pichler, Naisbitt & Park JACI, 127:74 81, 211 Th1/2/17/22 response Cytotoxicity 7
8 18/5/213 The Hapten Hypothesis Small compounds (<1Da) incomplete antigen Covalent binding Reactive chemical Cellular Soluble (serum) Protein conjugate Immune recognition Antigen presentation Cellular Response Immune recognition PI mechanism Pathways of T-cell activation Hapten mechanism TCR TCR Drug Reactive species MHC MHC Drug Reactive species Protein Reactive species Nature of the binding interaction Non-covalent Covalent 8
9 18/5/213 Abacavir Hypersensitivity: Translational Paradigm Discovery of HLA B*571 Replication Demonstration of cost effectiveness Randomised controlled trial (PREDICT 1) Implementation (UK from 26) Change in Peptide Repertoire 9
10 18/5/213 HLA B*57:1 and Abacavir Hypersensitivity Peptides from untreated cells standard peptide profile ABC treated cells show novel self peptides (2 25%) 25%) with Ile/Leu occupying C terminal anchor ptotein No change in peptide profile with closely related allotypes Illing et al, 213, Curr Opin Immunol Immunogenic HLA B*57:1 peptide complexes (after Illing et al, 213) 1
11 18/5/213 Patients with DRESS due to carbamazepine, allopurinol, sulfamethoxazole EBV, HHV 6 and HHV 7 reactivation in 76% Increased secretion of cutaneous homing markers, TNF α, IFNgamma CD8+ T cells recognised several EBV epitopes Culprit drugs triggered production of EBV from patient B cells?link between altered peptide repertoire and viral reactivation Nature Genetics, cases NNT for abacavir 12 NNT for flucloxacillin 13,819 Illumina 1 million SNP array Strong (P=1 3 ) association with SNP in LD with HLA B*57:1 Collaboration between UK DILIGEN and SAEC 11
12 18/5/213 Why HLA B*57:1? Abacavir Flucloxacillin in 1 patients 2. Elderly and prolonged course Chance finding or is there a common mechanism? Flucloxacillin Binding to HSA Lys19 Lys212 12
13 18/5/213 Flucloxacillin Induced Liver Injury Flucloxacillin forms an antigen in patients Jenkins et al., 29 Lys19 Nature Genetics 29 MISSING LINK: Lys212 Albumin conjugates in Evidence to show that reactions 8/8 patients (Lys 19, 212) to flucloxacillin are edriven by drug specific activation of cytotoxic CD8+ T lymphocytes Association between the expression of HLA B*571 and liver injury 4/64 controls 63/74 cases HLA B*571 restricted activation of flucloxacillin responsive T cells: The immunogenetic basis for DILI Patient cohort: Six patients with clinically well-defined flucloxacillin-mediated liver injury Phase 1 study: LTT negative in all patients IFN-gamma ELIspot positive in 5/6 patients IFN γ ELIspot Patient 178 Patient 18 Ø Ø flucloxacillin Patient 178 flucloxacillin IFN γγ IL 13 granzymeb Ø Monshi et al., Hepatology, 57, , 213 flucloxacillin 13
14 18/5/213 HLA B*571 restricted activation of flucloxacillin responsive T cells: The immunogenetic basis for DILI Patient cohort: Six patients with clinically well-defined flucloxacillin-mediated liver injury Phase 1 study: LTT negative in all patients IFN-gamma ELIspot positive in 5/6 patients Phase 2 study: Characterization of drugspecific cytotoxic T-cells Generation and characterization of T-cell clones Role of the HLA risk allele in the immune response Monshi et al., Hepatology, 57, , 213 Proliferation (cpmx1 3 ) CD4+ clone 1 2 CD4+ clone 1 2 CD8+ clone CD8+ clone CD8+ clone 1 2 Flucloxacillin (mm) ELIspot (sfu) Cytotoxic T cell clones IFN γ perforin granzymeb IL Flucloxacillin (mm) FasL IL 13 IFN γ flucloxacillin flucloxacillin flucloxacillin flucloxacillin flucloxacillin granzymeb FasL perforin IL 5 IL 13 HLA B*571 Restricted Activation of Flucloxacillin Responsive T cells: The Immunogenetic Basis for DILI Patient cohort: Six patients with clinically well-defined flucloxacillin-mediated liver injury Pilot study: LTT negative in all patients IFN-gamma ELIspot positive in 5/6 patients Phase 2 study: on-going Characterization of drugspecific cytotoxic T-cells Generation and characterization of T-cell clones Role of the HLA risk allele in the immune response Proliferation (cpmx1 3 ) Proliferation (cpmx1 3 ) Phenotype of Clones Patient HLA B allele IFN gamma ELIspot No. Of Flu specific clones CD4+ CD / HLA restriction with CD8+ clones No antibody + anti class I antibody + anti class II antibody Flucloxacillin (mm) Autologous (1) (2) (3) (1) (2) (3) (3) (1) (4) (2) No EBV s EBVs B*571 B*581 Other B alleles 14
15 18/5/213 Detection of Drug Specific T cell Responses in HLA Typed Drug Naïve Volunteers Dissemination of results HLA typed volunteer cohort READOUTS proliferation cytokine secretion cell surface markers Cell bank containing functional lymphocytes Provision of costimulatory signals through endogenous activators Proliferation assay against suspect chemicals Volunteer Demographics (N=4) Age Mean ±SD Range 29 ±1 years 18 6 years Gender Female Male 64% 36% 1 Fr requency Age White Indian Other Chinese Black 15
16 18/5/213 HLA B*57:1 Restricted Activation of Flucloxacillin Responsive T cells: The Immunogenetic Basis for DILI Volunteer cohort: Frozen PBMC from 26 drug-naive individuals expressing HLA-B*571 CD14 selection B*57:1 PBMC 7 days Flucloxacillin DCs DCs 8 days IFN γ ELIspot Naive T cell selection Flucloxacillin 125 Flucloxacillin 25 5 Proliferation (cpm) 4 31 CD8+ 35 flucloxacillinresponsive 3 T cell clones Flucloxacillin 2 3 Flucloxacillin: 3 patients Patient 1 Cholestatic hepatitis after 2 weeks of flucloxacillin Confirmed on biopsy T cell HLA B*57:1 Patient 2 Acute generalised exanthematous pustulosis Rechallenge with recurrence of reaction T cell IL8 HLA B*57:1 Patient 3 Anaphylaxis Positive skin and intradermal testing IgE HLA B*57:1 What factor(s) determine phenotype specificity? 16
17 18/5/213 Key knowledge gaps Frequency / Severity of Drug Hypersensitivity Chemistry Biology 1 = f 1 + f of drug 2 1of individual Relationship between drug protein binding and immunogenicity is not defined 2 The importance of genetic (HLA) predisposing factors (do they relate to the T cell response?) The immunological processes responsible for sensitization and tolerance are not defined 3 4 How T cells cause different forms of severe skin injury is not known Acknowledgements The University of Liverpool B Kevin Park Ana Alfirevic Dean Naisbitt Andrea Jorgensen Javier Vilar Dyfrig Hughes Stephane Bourgeois (Sanger Institute) Panagiotis Deloukas (Sanger Institute) Ann Daly and other DILIGEN members SERIOUS ADVERSE EVENT CONSORTIUM EPIGEN EUDRAGENE Funders: MRC, WT, DH, NIHR, EU FP7 17
Pathomechanism of Severe Drug Allergy
Pathomechanism of Severe Drug Allergy Werner J. Pichler, MD Division Allergology, RIA, Inselspital, University of Bern, CH 3010 Bern Switzerland ADR-AC GmbH Adverse Drug Reactions Analysis and Consulting
More informationChemically Reactive Drug Metabolites in Drug Discovery and Development Detection, Evaluation, and Risk Assessment
Chemically Reactive Drug Metabolites in Drug Discovery and Development Detection, Evaluation, and Risk Assessment Pacific Northwest Bio Meeting Seattle, WA, August 14, 2012 Thomas A. Baillie, PhD, DSc
More informationAOU Ospedali Riuniti - Ancona
AOU Ospedali Riuniti - Ancona Ospedale Materno-Infantile di Alta Specializzazione G. Salesi UOC Pediatria Allergia a farmaci e infezioni: tra coesistenza e casualità fabrizio franceschini Drug Hypersensitivity
More informationHealth economics and drug safety
Health economics and drug safety Professor Dyfrig Hughes FFRPS FBPhS FLSW Centre for Health Economics & Medicines Evaluation Bangor University, Wales @HughesDyfrig ADEs that are not reactions to a medicine
More informationExanthematous drug eruptions
Exanthematous drug eruptions Werner J. Pichler, M.D. Clinc for Rheumatology and clinical Immunology/Allergology, Inselspital, University of Bern Switzerland E-mail: werner.pichler@insel.ch Disclosure slide
More informationMultiple Drug Hypersensitivity
Multiple Drug Hypersensitivity Werner J Pichler ADR-AC GmbH Bern UPDATE ON DRUG HYPERSENSITIVITY, Bern, March 23rd 2017 Definition Multiple drug hypersensitivity (MDH) MDH is a syndrome that develops as
More informationPHM142 Autoimmune Disorders + Idiosyncratic Drug Reactions
PHM142 Autoimmune Disorders + Idiosyncratic Drug Reactions 1 Autoimmune Disorders Auto-reactivity: low physiological levels (e.g. tolerance) vs. pathogenic levels 80+ types of autoimmune diseases affect
More informationCutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population
O R I G I N A L A R T I C L E Eur Ann Allergy Clin Immunol Vol 50, N 1, 36-41, 2018 S. Büyüköztürk 1, Ç. Kekik 2, A.Z. Gökyiğit 3, F.İ. Tezer Filik 4i, G. Karakaya 4, S. Saygı 4i, A.B. Dursun 5, S. Kirbaş
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationInternational Consensus (ICON) on Drug Allergy
International Consensus (ICON) on Drug Allergy Allergy 2014; 69: 420 437 Pascal Demoly, N. Franklin Adkinson, Knut Brockow, Mariana Castells, Anca M. Chiriac, Paul A. Greenberger, David A. Khan, David
More informationα chain β chain C N C N β 2 α 1 β 1 α 2
a α chain c β chain C N C N β 2 m α chain b d N C N C β 1 α 2 Supplemental Figure 1 Major histocompatibility complex (MHC) class I and class II structures. (a, b)representation of the structure of the
More informationEtiology and Pathogenesis of Adverse Drug Reactions
French LE (ed): Adverse Cutaneous Drug Eruptions. Chem Immunol Allergy. Basel, Karger, 2012, vol 97, pp 32 46 Etiology and Pathogenesis of Adverse Drug Reactions O. Hausmann B. Schnyder W.J. Pichler Department
More information3 Medicine; 4 Pediatrics; 5 Pathology, Schulich School of Medicine and Dentistry; 6 Siebens-Drake Medical Research
SEVERE BULLOUS HYPERSENSITIVITY REACTIONS AFTER EXPOSURE TO CARBAMAZEPINE IN A HAN-CHINESE CHILD WITH A POSITIVE HLA- B*1502 AND NEGATIVE IN VITRO TOXICITY ASSAYS: EVIDENCE FOR DIFFERENT PATHOPHYSIOLOGICAL
More informationDrug Allergy A Guide to Diagnosis and Management
Drug Allergy A Guide to Diagnosis and Management (Version 1 April 2015 updated April 2018) Author: Jed Hewitt Chief Pharmacist, Governance & Professional Practice Date of Preparation: April 2015 Updated:
More informationDrug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests
Toxicology 194 (2004) 179 196 Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests Dean J. Naisbitt Department of Pharmacology, The Sherrington
More informationPrevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening
CMAJ Cases Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening Suran L. Fernando MB BS PhD, Andrew J. Broadfoot MB BS Previously published at www.cmaj.ca
More informationAdverse drug reactions
Medications William Smith Adverse drug reactions Allergy? Side-effect? Intolerance? Background Adverse drug reactions (ADRs) vary from life-threatening anaphylaxis to minor common side-effects. Objective
More informationClassification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms
Review Int Arch Allergy Immunol 2016;171:166 179 Published online: December 14, 2016 Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms Werner J. Pichler a Oliver Hausmann
More informationScott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION
Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 11 T-Cell Activation, Differentiation, and Memory Copyright 2013 by W. H. Freeman and
More informationNew product information wording Extracts from PRAC recommendations on signals
12 October 2017 EMA/PRAC/610988/2017 Pharmacovigilance Risk Assessment Committee (PRAC) New product information wording Extracts from PRAC recommendations on signals Adopted at the 25-29 September 2017
More informationInteraction of Small Molecules with Specific Immune Receptors: The p-i Concept and its Consequences
Send Orders for Reprints to reprints@benthamscience.net Current Immunology Reviews, 2014, 10, 7-18 7 Interaction of Small Molecules with Specific Immune Receptors: The p-i Concept and its Consequences
More informationSkin Manifestations of Drug Reactions
Skin Manifestations of Drug Reactions Dr Carol Hlela, Division of Dermatology Department of Medicine, University of Cape Town and Red Cross Children s Hospital What are the Skin Manifestations of Drug
More informationDeterminants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco
Determinants of Immunogenicity and Tolerance Abul K. Abbas, MD Department of Pathology University of California San Francisco EIP Symposium Feb 2016 Why do some people respond to therapeutic proteins?
More informationInnovative in vitro models of toxicology assessments
Mechanism based Integrated Systems for the Prediction of Drug-Induced Liver Injury Innovative in vitro models of toxicology assessments Chris Goldring University of Liverpool London EUFEMED 2017 Drug-Induced
More informationIMMUNE EFFECTOR MECHANISMS. Cell-Mediated Reactions
IMMUNE EFFECTOR MECHANISMS Cell-Mediated Reactions T-Cell Cytoxicity Definition - cytotoxicity involving direct contact between CTLs and target cells, resulting in target cell lysis or apoptosis Mechanisms
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Drug Allergy. These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio
More informationEmergency Dermatology Dr Melissa Barkham
Emergency Dermatology Dr Melissa Barkham Spotlight Seminar 30 th September 2010 Why is this important? Urgent recognition and treatment of dermatologic emergencies can be life saving and prevent long term
More informationAntigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family
More informationHeterosubtypic immunity. Professor Ajit Lalvani FMedSci Chair of Infectious Diseases 14/07/2014
Protective cellular immune correlates against pandemic influenza: implications for universal vaccines 2 nd WHO Meeting on development and clinical trials of broadly protective influenza vaccines 5th 7th
More informationAn Evidenced-Based Approach to the Adult with a Morbilliform Eruption
Relatively An Evidenced-Based Approach to the Adult with a Morbilliform Eruption Ben Kaffenberger, MD Assistant Professor, Dermatology Director, Inpatient Dermatology Consult Service Ohio State University
More informationCellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence
Cellular Immunity in Aging and HIV: Correlates of Protection Janet E. McElhaney, MD Professor of Medicine Allan M. McGavin Chair in Research Geriatrics University of British Columbia Vancouver, BC and
More informationImmunological response to metallic implants
Immunological response to metallic implants Doc. dr. Peter Korošec Head of Laboratory for Clinical Immunology & Molecular Genetics Head of Research & Development Department University Clinic of Respiratory
More informationDanger Signs in Drug Hypersensitivity
Danger Signs in Drug Hypersensitivity Kathrin Scherer, MD*, Andreas J. Bircher, MD KEYWORDS Drug hypersensitivity Adverse drug reaction Clinical danger signs Immediate-type hypersensitivity Delayed-type
More informationPage 4: Antigens: Self-Antigens The body has a vast number of its own antigens called self-antigens. These normally do not trigger immune responses.
Common Characteristics of B and T Lymphocytes Graphics are used with permission of Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com). Page 1: Introduction While B and T lymphocytes
More informationImmune Regulation and Tolerance
Immune Regulation and Tolerance Immunoregulation: A balance between activation and suppression of effector cells to achieve an efficient immune response without damaging the host. Activation (immunity)
More informationCellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU
Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated
More informationPotential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion
Potential cross reactions between HIV 1 specific T cells and the microbiome Andrew McMichael Suzanne Campion Role of the Microbiome? T cell (and B cell) immune responses to HIV and Vaccines are influenced
More informationBachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES
Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,
More informationT cell-mediated immunity
T cell-mediated immunity Overview For microbes within phagosomes in phagocytes.cd4+ T lymphocytes (TH1) Activate phagocyte by cytokines studies on Listeria monocytogenes For microbes infecting and replicating
More informationClinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
nature publishing group translation Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing MA Martin 1, TE Klein 2, BJ Dong 3, M Pirmohamed 4, DW Haas 5 7
More informationCutaneous drug eruptions are seen commonly
REVIEW ARTICLE Cutaneous drug reactions in children Sandipan Dhar, Raghubir Banerjee, Rajib Malakar Department of Pediatric Dermatology, Institute of Child Health, Kolkata, West Bengal, India ABSTRACT
More informationClinical Study In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous Adverse Drug Reactions
Clinical and Developmental Immunology Volume 2012, Article ID 687532, 7 pages doi:10.1155/2012/687532 Clinical Study In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous
More informationPositive Rechallenge: What Clinical Trial Data Tell Us Julie Papay, Pharm.D. UCB BioSciences Global Patient Safety
Positive Rechallenge: What Clinical Trial Data Tell Us Julie Papay, Pharm.D. UCB BioSciences Global Patient Safety Drug-Induced Liver Injury (DILI) Conference XVI Wednesday 23 March 2016 The comments provided
More informationHow Reactive Metabolites Induce an Immune Response that Sometimes Leads to an Idiosyncratic Drug Reaction
How Reactive Metabolites Induce an Immune Response that Sometimes Leads to an Idiosyncratic Drug Reaction Jack Uetrecht, M.D., Ph.D. jack.uetrecht@utoronto.ca It is very difficult to study the mechanisms
More informationHow Reactive Metabolites Induce an Immune Response that Sometimes Leads to an Idiosyncratic Drug Reaction
How Reactive Metabolites Induce an Immune Response that Sometimes Leads to an Idiosyncratic Drug Reaction Jack Uetrecht, M.D., Ph.D. jack.uetrecht@utoronto.ca It is very difficult to study the mechanisms
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationImmunogenetics in Vaccine Design and Pharmacogenetics
Immunogenetics in Vaccine Design and Pharmacogenetics M. Sue Leffell, Ph.D. Johns Hopkins University School of Medicine Vaccine Achievements Vaccination is one of greatest public health achievements Almost
More informationLecture 03: Drug allergy
Lecture 03: Drug allergy 1. Basic Information Author: Netherlands Pharmacovigilance Centre Lareb Version date: 17 Nov 2017 Content: This hand-out describes Drug allergy and provides background information
More informationThird line of Defense
Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)
More informationCytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands
Cytotoxicity assays Rory D. de Vries, PhD 1 1 Viroscience lab, Erasmus MC, Rotterdam, the Netherlands Anti-influenza immunity Humoral / CD4+ / CD8+ / NK? Function of CTL Elimination of virus-infected cells?
More informationCellular Pathology of immunological disorders
Cellular Pathology of immunological disorders SCBM344 Cellular and Molecular Pathology Witchuda Payuhakrit, Ph.D (Pathobiology) witchuda.pay@mahidol.ac.th Objectives Describe the etiology of immunological
More informationHow T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do? Monoclonal antibody approach
How T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do By the early 1980s, much about T cell function was known, but the receptor genes had not been identified
More informationA second type of TCR TCR: An αβ heterodimer
How s recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do By the early 1980s, much about function was known, but the receptor genes had not been identified Recall
More informationThe mechanisms of common drug hypersensitivities and implications for testing
The mechanisms of common drug hypersensitivities and implications for testing R J Heddle 17 May 2016 Adverse Drug Reactions (ADR) Type A 85-90% of ADR Any individual, given sufficient dose & exposure Predictable
More informationStevens Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections
BRIEF COMMUNICATION http://dx.doi.org/10.4110/in.2016.16.4.256 pissn 1598-2629 eissn 2092-6685 Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections
More informationD.R.E.S.S. Syndrome An update. David H. Peng MD MPH Department of Dermatology Keck School of Medicine of USC
D.R.E.S.S. Syndrome An update David H. Peng MD MPH Department of Dermatology Keck School of Medicine of USC I have no disclosures I will be discussing off label uses for medications Maculopapular Morbilliform
More informationThird line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!
Topic 8 Specific Immunity (adaptive) (18) Topics - 3 rd Line of Defense - B cells - T cells - Specific Immunities 1 3 rd Line = Prophylaxis via Immunization! (a) A painting of Edward Jenner depicts a cow
More informationSupporting Information
Supporting Information Chapuis et al. 10.1073/pnas.1113748109 SI Methods Selection of Patients, Targets, Isolation, and Expansion of Melanoma- Specific CTL Clones. Patients were HLA-typed, and their tumors
More informationAlessandra Franco MD PhD UCSD School of Medicine Department of Pediatrics Division of Allergy Immunology and Rheumatology
Immunodominant peptides derived from the heavy constant region of IgG1 stimulate natural regulatory T cells: identification of pan- HLA binders for clinical translation Alessandra Franco MD PhD UCSD School
More informationSignificance of the MHC
CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationImmune pathomechanism of drug hypersensitivity reactions
Immune pathomechanism of drug hypersensitivity reactions Werner J. Pichler, MD, a Dean J. Naisbitt, PhD, b and B. Kevin Park, PhD b Bern, Switzerland, and Liverpool, United Kingdom Drug hypersensitivity
More informationAmino acid sequences in the β chain HLA- DRB*0401 molecules dictate susceptibility to RA Amino Acids in the Shared Epitope
MHC/self-peptide MHC/Vβ TCR Vβx + Vβx T cell Induction of + TH1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and APC type I diabetes TCR Vβx Activated
More informationPathophysiology of autoimmune and allergic diseases. Hypersensitivity reactions type II type IV
Pathophysiology of autoimmune and allergic diseases Hypersensitivity reactions type II type IV Audrey NOSBAUM, Florence HACARD, Marc VOCANSON, Frédéric BERARD, Jean François NICOLAS Allergologie et Immunologie
More informationDrug induced allergy and hypersensitivity
Drug induced allergy and hypersensitivity Yunita Sari Pane, Aznan Lelo Dept. Pharmacology & Therapeutic School of Medicine Universitas Sumatera Utara 13 Mei 2009, KBK-FK USU, Medan Drug Allergy Adverse
More informationMicro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier
Micro 204 Cytotoxic T Lymphocytes (CTL) Lewis Lanier Lewis.Lanier@ucsf.edu Lymphocyte-mediated Cytotoxicity CD8 + αβ-tcr + T cells CD4 + αβ-tcr + T cells γδ-tcr + T cells Natural Killer cells CD8 + αβ-tcr
More informationAn unpredictable, dose-independent adverse drug reaction which is immunologically or IgEmediated.
R H E U M A T I S M D I S O R D E R S A N D A L L E R G I E S APPROACH TO DRUG ALLERGY Dr Bernard Thong DEFINITION OF DRUG ALLERGY An unpredictable, dose-independent adverse drug reaction which is immunologically
More informationThey determine if there will be an immune response. Determine functions associated with immune response, but not specific to Ag.
Appendices A They determine if there will be an immune response. Antigen receptor genes in T cells (TCR) and B cell (Ig) Determine functions associated with immune response, but not specific to Ag. MHC
More informationA genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury Jonathan B Singer 1,2, Steve Lewitzky 1,2, Elisabeth Leroy 1, Fan Yang 1, Xiaojun Zhao 1, Lloyd Klickstein 1,
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationDefensive mechanisms include :
Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral
More informationEvaluation of Drug Hypersensitivity by flow cytometry (technical session)
Allergy School on Allergic Reactions to Drugs From Phenotype to Genotype Evaluation of Drug Hypersensitivity by flow cytometry (technical session) Enrique Gomez 19-21 September 2013 Carlos Haya - Hospital.
More informationPersonalized Medical Care:Recognition, Management, and Maybe Prevention of Cutaneous Hypersensitivity Reactions
Personalized Medical Care:Recognition, Management, and Maybe Prevention of Cutaneous Hypersensitivity Reactions Bernard A. Cohen, M.D. Johns Hopkins Children s Center Baltimore, Maryland (NO disclosures)
More informationAttribution: University of Michigan Medical School, Department of Microbiology and Immunology
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More information8/8/2016. Overview. Back to Basics: Immunology. Adverse Reactions to Drugs: Dispelling Myths
Adverse Reactions to Drugs: Dispelling Myths Allison Ramsey, MD NPA Annual Conference September 30, 2016 Overview Review of types of hypersensitivity reactions Penicillin allergy IV contrast allergy Local
More informationThe Adaptive Immune Responses
The Adaptive Immune Responses The two arms of the immune responses are; 1) the cell mediated, and 2) the humoral responses. In this chapter we will discuss the two responses in detail and we will start
More informationChapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group
FIT Board Review Corner September 2015 Welcome to the FIT Board Review Corner, prepared by Andrew Nickels, MD, and Sarah Spriet, DO, senior and junior representatives of ACAAI's Fellows-In-Training (FITs)
More informationScott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION
Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 13 Effector Responses: Cell- and Antibody-Mediated Immunity Copyright 2013 by W. H.
More informationImmunotherapy on the Horizon: Adoptive Cell Therapy
Immunotherapy on the Horizon: Adoptive Cell Therapy Joseph I. Clark, MD, FACP Professor of Medicine Loyola University Chicago Stritch School of Medicine Maywood, IL June 23, 2016 Conflicts of Interest
More informationManaging Penicillin Allergy
Managing Penicillin Allergy Brian T. Kelly, MD MA April 12, 2019 Objectives Review penicillin allergy prevalence, morbidity, and management Describe the penicillin testing and oral challenge process Provide
More informationFoundations in Microbiology
Foundations in Microbiology Fifth Edition Talaro Chapter 15 The Acquisition of Specific Immunity and Its Applications Chapter 15 2 Chapter Overview 1. Development of the Dual Lymphocyte System 2. Entrance
More informationSystems biology approach to ximelagatran injury
Note - presentation notes may be read by double clicking on the icon to the left FDA/CDER, PhRMA, AASLD: Recent Research Advances in Drug-Induced Liver Injury 2009-04-08 Systems biology approach to ximelagatran
More informationAdaptive (acquired) immunity. Professor Peter Delves University College London
Adaptive (acquired) immunity Professor Peter Delves University College London p.delves@ucl.ac.uk Haematopoiesis Haematopoiesis Lymphocytes = adaptive response Recognition of pathogens by adaptive cells,
More informationProf. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology
By Prof. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology Lecture objectives: At the end of the lecture you should be able to: Enumerate features that characterize acquired immune response
More informationACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT
ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes
More informationCentral tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response
Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. Mechanisms of Immune Tolerance ACTIVATION (immunity) SUPPRESSION (tolerance)
More informationMechanisms of Immune Tolerance
Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. ACTIVATION (immunity) SUPPRESSION (tolerance) Autoimmunity Immunodeficiency
More informationIntroduction to Immunology and the Immune System
Introduction to Immunology and the Immune System Assistant professor Dr. Aida R. Al-Derzi M.B.Ch.B; M.Sc; FICM/Path Dept. of Microbiology/College of Medicine/Baghdad University Introduction to Immunology
More informationRequirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope
+ T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +
More informationOXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT
OXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT Lung-Chang Lin, 1,2 Ping-Chin Lai, 3 Sheau-Fang Yang, 4 and Rei-Cheng Yang 1,5 Departments of 1 Pediatrics and 4 Pathology, Kaohsiung Medical
More informationI. Critical Vocabulary
I. Critical Vocabulary A. Immune System: a set of glands, tissues, cells, and dissolved proteins that combine to defend against non-self entities B. Antigen: any non-self chemical that triggers an immune
More informationInnate and Cellular Immunology Control of Infection by Cell-mediated Immunity
Innate & adaptive Immunity Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity Helen Horton PhD Seattle Biomedical Research Institute Depts of Global Health & Medicine, UW Cellular
More informationTriggers Allergens Allografts Helminths Viruses Tissue Injury
Rothenberg et al. Adv Immunol; 2001 Triggers Allergens Allografts Helminths Viruses Tissue Injury Rothenberg et al. Adv Immunol; 2001 Triggers Allergens Allografts Helminths Viruses Tissue Injury Cytotoxic
More informationIn drug hypersensitivity, 2 extremely polymorphic systems
REVIEW ARTICLE The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors Werner J. Pichler Abstract: The immune response in drug hypersensitivity is normally explained by the hapten hypothesis.
More informationDiseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.
Diseases of Immunity 2017 CL Davis General Pathology Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Autoimmunity Reflects a loss of immunologic tolerance Mechanisms Auto-antibodies
More informationT cell maturation. T-cell Maturation. What allows T cell maturation?
T-cell Maturation What allows T cell maturation? Direct contact with thymic epithelial cells Influence of thymic hormones Growth factors (cytokines, CSF) T cell maturation T cell progenitor DN DP SP 2ry
More informationEndeavour College of Natural Health endeavour.edu.au
Endeavour College of Natural Health endeavour.edu.au BIOH122 Human Biological Science 2 Session 9 Immune System 2 Bioscience Department Endeavour College of Natural Health endeavour.edu.au o Adaptive (Specific)
More informationSupplemental materials
Supplemental materials 1 Supplemental Fig. 1 Immunogram This immunogram summarizes patient clinical data and immune parameters at corresponding time points for Patient IMF-32. The top panel illustrates
More informationThe Effects of Induced Aggregation of IgG and Insulin Preparations on In Vitro T Cell Stimulation
Website home page picture here The Effects of Induced Aggregation of IgG and Insulin Preparations on In Vitro T Cell Stimulation 2 nd EIP Symposium 17 th -19 th November 29 Immune Responses to Protein
More information